{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:52:27Z","timestamp":1791381147720,"version":"4.3.3"},"reference-count":56,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2026,10,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Achieving early therapeutic trough concentrations (Cmin) of voriconazole (VRC) is crucial for treatment efficacy and to avoid side effects. Since VRC Cmin are influenced by numerous determinants, this multicenter retrospective study aimed to develop a multiparametric dosing algorithm for individualizing initial VRC maintenance doses. Individual data regarding VRC Cmin from adult patients and associated parameters (age, sex, underlying disease [presence of hematological disease\/other], weight, dose, route of administration, indication: curative\/prophylactic, cytochrome [CYP]2C19 and 3A genotypes, C-reactive protein [CRP], transaminases, bilirubin, and proton pump inhibitor treatment) were collected from six previously published studies and routine care data from seven laboratories (building cohort). A mixed-effects model predicting VRC Cmin was developed on this building cohort using a stepwise cross-validation procedure and then externally validated on an independent cohort (validation cohort). The building and validation cohorts included 977 VRC Cmin in 277 patients and 47 VRC Cmin in 33 patients, respectively. The initial model, which integrated VRC daily dose, CYP2C19 genotype, and CRP, was enriched by two additional covariates: age and underlying disease. The final model had an\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      \u00b2 of 0.69 but tended to underestimate low VRC Cmin and overestimate high VRC Cmin. Finally, a formula derived from this final model was proposed and integrated into an Excel sheet to individualize initial VRC maintenance doses. The developed predictive model allowed for the creation of a multiparametric dosing algorithm for the individualization of initial VRC maintenance doses. The benefit of this algorithm will soon be evaluated in a prospective pilot study to improve initial VRC exposure.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00278-26","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:06:15Z","timestamp":1789135575000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses"],"prefix":"10.1128","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-3847","authenticated-orcid":true,"given":"Elodie","family":"Gautier-Veyret","sequence":"first","affiliation":[{"name":"Univ. Grenoble Alpes, INSERM U1300, HP2 Laboratory","place":["Grenoble, France"]},{"name":"Univ. Grenoble Alpes, CHU Grenoble Alpes, Laboratoire de Pharmacologie, Pharmacog\u00e9netique et Toxicologie","place":["Grenoble, France"]},{"name":"R\u00e9seau Francophone de Pharmacog\u00e9n\u00e9tique (RNPGX), H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP)","place":["Paris, France"]},{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-6255","authenticated-orcid":true,"given":"Othilie","family":"Giannoni","sequence":"additional","affiliation":[{"name":"Pharmacie des H\u00f4pitaux Universitaire de Gen\u00e8ve","place":["Geneva, Switzerland"]},{"name":"Section des Sciences Pharmaceutiques, Institut des Sciences Pharmaceutiques de Suisse Occidentale, Universit\u00e9 Gen\u00e8ve Suisse","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Manceau","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, Inserm CIC1406, CHU Grenoble Alpes","place":["Grenoble, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2048-2154","authenticated-orcid":true,"given":"Capucine","family":"Arrive","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, INSERM U1300, HP2 Laboratory","place":["Grenoble, France"]},{"name":"Univ. Grenoble Alpes, CHU Grenoble Alpes, Laboratoire de Pharmacologie, Pharmacog\u00e9netique et Toxicologie","place":["Grenoble, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8124-5293","authenticated-orcid":true,"given":"Sylvia","family":"Klomp","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05xvt9f17","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center","place":["Leiden, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-1626","authenticated-orcid":true,"given":"Matthieu","family":"Roustit","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, Inserm CIC1406, CHU Grenoble Alpes","place":["Grenoble, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1693-7431","authenticated-orcid":true,"given":"Fabien","family":"Lamoureux","sequence":"additional","affiliation":[{"name":"R\u00e9seau Francophone de Pharmacog\u00e9n\u00e9tique (RNPGX), H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP)","place":["Paris, France"]},{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]},{"name":"UNIROUEN, INSERM U1096, CHU Rouen, Department of Pharmacology, Normandie University","place":["Rouen, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0302-6049","authenticated-orcid":true,"given":"Benjamin","family":"Hennart","sequence":"additional","affiliation":[{"name":"R\u00e9seau Francophone de Pharmacog\u00e9n\u00e9tique (RNPGX), H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP)","place":["Paris, France"]},{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]},{"name":"CHU Lille, Service de Toxicologie et G\u00e9nopathies","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-9648","authenticated-orcid":true,"given":"Caroline","family":"Solas","sequence":"additional","affiliation":[{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]},{"id":[{"id":"https:\/\/ror.org\/035xkbk20","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Pharmacocin\u00e9tique et Toxicologie, H\u00f4pital La Timone, Aix-Marseille University, APHM, UMR \"Emergence des Pathologies Virales\" Inserm 1207 IRD 190","place":["Marseille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8818-8033","authenticated-orcid":true,"given":"Sarah","family":"Baklouti","sequence":"additional","affiliation":[{"name":"R\u00e9seau Francophone de Pharmacog\u00e9n\u00e9tique (RNPGX), H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP)","place":["Paris, France"]},{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]},{"id":[{"id":"https:\/\/ror.org\/03vcx3f97","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Pharmacocin\u00e9tique et Toxicologie, IFB, H\u00f4pital Purpan","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8534-224X","authenticated-orcid":true,"given":"Celine","family":"Verstuyft","sequence":"additional","affiliation":[{"name":"R\u00e9seau Francophone de Pharmacog\u00e9n\u00e9tique (RNPGX), H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP)","place":["Paris, France"]},{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]},{"id":[{"id":"https:\/\/ror.org\/00pg5jh14","id-type":"ROR","asserted-by":"publisher"}],"name":"Service de G\u00e9n\u00e9tique Mol\u00e9culaire, Pharmacog\u00e9n\u00e9tique et Hormonologie de Bic\u00eatre, H\u00f4pitaux Universitaires Paris-Saclay, Assistance Publique-H\u00f4pitaux de Paris","place":["Le Kremlin-Bic\u00eatre, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-0958","authenticated-orcid":true,"given":"Christelle","family":"Boglione-Kerrien","sequence":"additional","affiliation":[{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]},{"id":[{"id":"https:\/\/ror.org\/05qec5a53","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical and Biological Pharmacology and Pharmacovigilance, Pharmacoepidemiology and Drug Information Centre, Rennes University Hospital","place":["Rennes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-5552","authenticated-orcid":true,"given":"Jesse J.","family":"Swen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05xvt9f17","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center","place":["Leiden, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-3596","authenticated-orcid":true,"given":"Nicolas","family":"Pallet","sequence":"additional","affiliation":[{"name":"R\u00e9seau Francophone de Pharmacog\u00e9n\u00e9tique (RNPGX), H\u00f4pital Europ\u00e9en Georges-Pompidou (HEGP)","place":["Paris, France"]},{"name":"Service de Biochimie, Assistance Publique H\u00f4pitaux de Paris, Assistance Publique H\u00f4pitaux de Paris","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4451-4216","authenticated-orcid":true,"given":"Anette","family":"Veringa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03cv38k47","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen","place":["Groningen, the Netherlands"]},{"name":"Department of Clinical Pharmacy, OLVG","place":["Amsterdam, the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-0288","authenticated-orcid":true,"given":"Jan Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03cv38k47","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen","place":["Groningen, the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6463-297X","authenticated-orcid":true,"given":"Takahiro","family":"Yamada","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00ndx3g44","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Hospital Pharmacy, Hamamatsu University School of Medicine","place":["Hamamatsu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-3789","authenticated-orcid":true,"given":"Takafumi","family":"Naito","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03a2hf118","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pharmacy, Shinshu University Hospital","place":["Matsumoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Stanke-Labesque","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, INSERM U1300, HP2 Laboratory","place":["Grenoble, France"]},{"name":"Univ. Grenoble Alpes, CHU Grenoble Alpes, Laboratoire de Pharmacologie, Pharmacog\u00e9netique et Toxicologie","place":["Grenoble, France"]},{"name":"Groupe Suivi Th\u00e9rapeutique Pharmacologique-Personnalisation des traitements (STP-PT) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique (SFPT)","place":["Tours, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Khouri","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, Inserm CIC1406, CHU Grenoble Alpes","place":["Grenoble, France"]},{"id":[{"id":"https:\/\/ror.org\/02rx3b187","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Grenoble Alpes, Pharmacovigilance Unit, Grenoble Alpes University Hospital","place":["Grenoble, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Therapeutic Drug Monitoring and Personalization Treatment group of the French Society of Pharmacology and Therapeutics and the French-Speaking Network of Pharmacogenetics (RNPGx)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.152900"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.71"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis599"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/524669"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw045"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.05.019"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3640-3645.2005"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4683-6"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/504810"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3310-z"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1642"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1641"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102089"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw349"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad293"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04838-14"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2294-5"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.809"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106078"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000536"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.08.121"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13208"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.982981"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15916"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14661"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/656527"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-024-00831-8"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12422"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0054"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.12.024"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.12.003"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14578"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.583"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1157944"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.935"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.846411"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02990.x"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008327537"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.717932"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-023-00320-z"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107627"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46107"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13887"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01069-z"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.021"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121239"},{"key":"e_1_3_5_50_2","unstructured":"PANTOPRAZOLE SUMMARY OF PRODUCT CHARACTERISTICS. 2023. EMEA. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/pantozol-control-epar-product-information_en.pdf"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106750"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091920"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01274-y"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03359-2"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746030-00003"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.06.001"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz499"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00278-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00278-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:39Z","timestamp":1791378099000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00278-26"}},"subtitle":[],"editor":[{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,7]]}},"alternative-id":["10.1128\/aac.00278-26"],"URL":"https:\/\/doi.org\/10.1128\/aac.00278-26","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"2026-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00278-26"}}